about
Pseudomonas Exotoxin A: optimized by evolution for effective killingAndrogen deprivation of prostate cancer: Leading to a therapeutic dead endA recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometryEnterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.Treatment of metastatic prostate cancer after STAMPEDE.A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cellsMethadone as a "Tumor Theralgesic" against Cancer.In Vitro Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer.Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells.Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.Tumor-Specific Induction of the Intrinsic Apoptotic Pathway-A New Therapeutic Option for Advanced Prostate Cancer?
P50
Q26781376-A1D04893-C6D2-42E8-81D7-2AB69F32B391Q26799813-C4A874FB-597B-4781-A7EF-C5FD6CF2B376Q33237016-8207B283-49CA-4716-AC53-7BAFD0AA1907Q34420372-49973E65-B8ED-4D8B-9680-B7C9B09DB123Q36962425-16B4DE11-B0C6-4BE8-8E68-6B14AE87BFBDQ38766556-5E9EA33F-7292-4525-8359-C2C808F135F8Q38896408-8FDD8DBF-F504-40FD-85FA-F84358574461Q38955091-5FD804A8-65F0-498E-BA57-B730447E9206Q39017235-CF95FBA0-2207-49FE-806E-F14F46608359Q39644680-F66F12DE-2FAC-43E9-A526-435674167796Q39670891-15C1DD51-F203-46E4-A6C2-839A0A596A51Q39770729-82194A19-1932-4A90-BC6B-BDE07ACE76C6Q40043635-9A07DE02-49CC-4E14-A191-E9BED7286E4AQ40246099-ECFBDC49-5891-4AE0-A760-E1D0A8FAC460Q42353513-7FF36A21-26C1-4227-BABA-F8E6C1E91BC7Q42575116-F8D1CFE6-207E-4CCA-8ED8-90D142FE0680Q47150971-401BE987-C1B1-4FA2-ADA8-D3F9B8B4A000Q47255225-7D771D76-DD9B-4456-9850-D088F03F185BQ47349096-191AEDAD-968C-4698-B7AB-35D05E005BF2Q50146211-0D25B057-1FFD-4006-B2A3-32078E36B536Q51737266-515B826C-17FD-4E12-B1F8-2E584350A142Q51766972-61D83BA0-8905-417B-B790-67ECB30552CDQ53272743-C49C74B6-C4DA-4E9C-9700-1CBD7E5D5877Q54377694-72E60EF2-185B-430B-8282-9D62233F5664Q91942429-DBBCC4CB-E05E-48F5-8BBE-2E79BFDCF2CE
P50
description
researcher ORCID ID = 0000-0001-6779-4325
@en
name
Philipp Wolf
@ast
Philipp Wolf
@en
Philipp Wolf
@es
Philipp Wolf
@nl
type
label
Philipp Wolf
@ast
Philipp Wolf
@en
Philipp Wolf
@es
Philipp Wolf
@nl
prefLabel
Philipp Wolf
@ast
Philipp Wolf
@en
Philipp Wolf
@es
Philipp Wolf
@nl
P214
P214
P31
P496
0000-0001-6779-4325
P734
P735
P7859
viaf-57746557